Luukkonen: DSM-5: Merkkisysteeminen diagnostiikka

[Psykopatologia]

Terveystiede | Lääketiede, farmasia | Filosofia, psykologia |
http://granum.uta.fi/granum/kirjanTiedo ... e_id=24264

Luukkonen, Pertti
DSM-5: merkkisysteeminen diagnostiikka. DSM-5-sarja I
Luukkosen Kliinisen PsykoPatologian Sarja 9 (LKPPS 9)

Laajuus: 61 sivua
Julkaisuvuosi: 2014
ISBN/ISSN: 978-952-68133-0-1/1799-8514
Kieli: suomi
Kustantaja: Psykopatologia

Ensimmäinen kriittinen arvio DSM-5:n kenttäkokeista (field trials) asteikkojen reliabiliteettien estimaattien
määrittämiseksi (kappa-kertoimet).

Task Force 36 kuvana! - 1) DSM:n historia: "One" (1952), II (1968), III (1980), IV (1994), IV-TR (2000) & 5 (2013).
- 2) DSM-5-manuaalin kuvaus sekä kenttäkokeiden (field trials) kriittinen arviointi. - 3) Deskriptiivisen merkki-
systeemisen diagnostiikan kuvaus Anders Breivikin tapauksen valossa. - 13 taulukkoa. - Sanasto. - Kirjallisuus.

1. DSM-5 (Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition)
2. APA (American Psychiatric Association)
3. merkkisysteeminen diagnostiikka (psykiatrinen)
4. reliabiliteetti
5. Anders Behring Breivik

- Postitus SAMANA päivänä - 1,40 €.

24.90 € Osta kirja
http://granum.uta.fi/granum/hakutulos.p ... &aihe_id=7

[Psykopatologia]

_

[Psykopatologia]

Google
DSM-5 Table of Contents xliv + 947 (991) p.

DSM-5 Classification xiii
Preface xli

Section I: DSM-5 Basics

Introduction 5
Use of the Manual 19
Cautionary Statement for Forensic Use of DSM-5 25

Section II: Diagnostic Criteria and Codes

Neurodevelopmental Disorders 31

Intellectual Disabilities
Intellectual Disability (Intellectual Developmental Disorder)
Global Developmental Delay
Unspecified Intellectual Disability (Intellectual Developmental Disorder)
Communication Disorders
Language Disorder
Speech Sound Disorder (previously Phonological Disorder)
Childhood-Onset Fluency Disorder (Stuttering)
Social (Pragmatic) Communication Disorder
Unspecified Communication Disorder
Autism Spectrum Disorder
Autism Spectrum Disorder
Attention-Deficit/Hyperactivity Disorder
Attention-Deficit/Hyperactivity Disorder
Other Specified Attention-Deficit/Hyperactivity Disorder
Unspecified Attention-Deficit/Hyperactivity Disorder
Specific Learning Disorder
Specific Learning Disorder
Motor Disorders
Developmental Coordination Disorder
Stereotypic Movement Disorder
Tic Disorders
Tourette’s Disorder
Persistent (Chronic) Motor or Vocal Tic Disorder
Provisional Tic Disorder
Other Specified Tic Disorder
Unspecified Tic Disorder
Other Neurodevelopmental Disorders
Other Specified Neurodevelopmental Disorder
Unspecified Neurodevelopmental Disorder

Schizophrenia Spectrum and Other Psychotic Disorders 31

Schizotypal (Personality) Disorder
Delusional Disorder
Brief Psychotic Disorder
Schizophreniform Disorder
Schizophrenia
Schizoaffective Disorder
Substance/Medication-Induced Psychotic Disorder
Psychotic Disorder Due to Another Medical Condition

Catatonia
Catatonia Associated With Another Mental Disorder (Catatonia Specifier)
Catatonic Disorder Due to Another Medical Condition
Unspecified Catatonia

Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
Unspecified Schizophrenia Spectrum and Other Psychotic Disorder

Bipolar and Related Disorders 123

Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
Substance/Medication-Induced Bipolar and Related Disorder
Bipolar and Related Disorder Due to Another Medical Condition
Other Specified Bipolar and Related Disorder
Unspecified Bipolar and Related Disorder

Depressive Disorders 155

Disruptive Mood Dysregulation Disorder
Major Depressive Disorder, Single and Recurrent Episodes
Persistent Depressive Disorder (Dysthymia)
Premenstrual Dysphoric Disorder
Substance/Medication-Induced Depressive Disorder
Depressive Disorder Due to Another Medical Condition
Other Specified Depressive Disorder
Unspecified Depressive Disorder

Anxiety Disorders 189

Separation Anxiety Disorder
Selective Mutism
Specific Phobia
Social Anxiety Disorder (Social Phobia)
Panic Disorder
Panic Attack (Specifier)
Agoraphobia
Generalized Anxiety Disorder
Substance/Medication-Induced Anxiety Disorder
Anxiety Disorder Due to Another Medical Condition
Other Specified Anxiety Disorder
Unspecified Anxiety Disorder

Obsessive-Compulsive and Related Disorders 235

Obsessive-Compulsive Disorder
Body Dysmorphic Disorder
Hoarding Disorder
Trichotillomania (Hair-Pulling Disorder)
Excoriation (Skin-Picking) Disorder
Substance/Medication-Induced Obsessive-Compulsive and Related Disorder
Obsessive-Compulsive and Related Disorder Due to Another Medical Condition
Other Specified Obsessive-Compulsive and Related Disorder
Unspecified Obsessive-Compulsive and Related Disorder

Trauma- and Stressor-Related Disorders 265

Reactive Attachment Disorder
Disinhibited Social Engagement Disorder
Posttraumatic Stress Disorder
Acute Stress Disorder
Adjustment Disorders
Other Specified Trauma- and Stressor-Related Disorder
Unspecified Trauma- and Stressor-Related Disorder

Dissociative Disorders 291

Dissociative Identity Disorder
Dissociative Amnesia
Depersonalization/Derealization Disorder
Other Specified Dissociative Disorder
Unspecified Dissociative Disorder

Somatic Symptom and Related Disorders 309

Somatic Symptom Disorder
Illness Anxiety Disorder
Conversion Disorder (Functional Neurological Symptom Disorder)
Psychological Factors Affecting Other Medical Conditions
Factitious Disorder
Other Specified Somatic Symptom and Related Disorder
Unspecified Somatic Symptom and Related Disorder

Feeding and Eating Disorders 329

Pica
Rumination Disorder
Avoidant/Restrictive Food Intake Disorder
Anorexia Nervosa
Bulimia Nervosa
Binge-Eating Disorder
Other Specified Feeding or Eating Disorder
Unspecified Feeding or Eating Disorder

Elimination Disorders 355

Enuresis
Encopresis
Other Specified Elimination Disorder
Unspecified Elimination Disorder

Sleep-Wake Disorders 361

Insomnia Disorder
Hypersomnolence Disorder
Narcolepsy

Breathing-Related Sleep Disorders
Obstructive Sleep Apnea Hypopnea
Central Sleep Apnea
Sleep-Related Hypoventilation

Circadian Rhythm Sleep-Wake Disorders

Parasomnias
Non–Rapid Eye Movement Sleep Arousal Disorders
...Sleepwalking
...Sleep Terrors
Nightmare Disorder
Rapid Eye Movement Sleep Behavior Disorder

Restless Legs Syndrome

Substance/Medication-Induced Sleep Disorder
Other Specified Insomnia Disorder
Unspecified Insomnia Disorder
Other Specified Hypersomnolence Disorder
Unspecified Hypersomnolence Disorder
Other Specified Sleep-Wake Disorder
Unspecified Sleep-Wake Disorder

Sexual Dysfunctions 423

Delayed Ejaculation
Erectile Disorder
Female Orgasmic Disorder
Female Sexual Interest/Arousal Disorder
Genito-Pelvic Pain/Penetration Disorder
Male Hypoactive Sexual Desire Disorder
Premature (Early) Ejaculation
Substance/Medication-Induced Sexual Dysfunction
Other Specified Sexual Dysfunction
Unspecified Sexual Dysfunction

Gender Dysphoria 451

Gender Dysphoria
Other Specified Gender Dysphoria
Unspecified Gender Dysphoria

Disruptive, Impulse-Control, and Conduct Disorders 461

Oppositional Defiant Disorder
Intermittent Explosive Disorder
Conduct Disorder
Antisocial Personality Disorder
Pyromania
Kleptomania
Other Specified Disruptive, Impulse-Control, and Conduct Disorder
Unspecified Disruptive, Impulse-Control, and Conduct Disorder

Substance-Related and Addictive Disorders 481

Substance-Related Disorders
...Substance Use Disorders
...Substance-Induced Disorders
......Substance Intoxication and Withdrawal
......Substance/Medication-Induced Mental Disorders

...Alcohol-Related Disorders
...Alcohol Use Disorder
...Alcohol Intoxication
...Alcohol Withdrawal
...Other Alcohol-Induced Disorders
...Unspecified Alcohol-Related Disorder

...Caffeine-Related Disorders
...Caffeine Intoxication
...Caffeine Withdrawal
...Other Caffeine-Induced Disorders
...Unspecified Caffeine-Related Disorder

...Cannabis-Related Disorders
...Cannabis Use Disorder
...Cannabis Intoxication
...Cannabis Withdrawal
...Other Cannabis-Induced Disorders
...Unspecified Cannabis-Related Disorder

...Hallucinogen-Related Disorders
...Phencyclidine Use Disorder
...Other Hallucinogen Use Disorder
...Phencyclidine Intoxication
...Other Hallucinogen Intoxication
...Hallucinogen Persisting Perception Disorder
...Other Phencyclidine-Induced Disorders
...Other Hallucinogen-Induced Disorders
...Unspecified Phencyclidine-Related Disorder
...Unspecified Hallucinogen-Related Disorder

...Inhalant-Related Disorders
...Inhalant Use Disorder
...Inhalant Intoxication
...Other Inhalant-Induced Disorders
...Unspecified Inhalant-Related Disorder

...Opioid-Related Disorders
...Opioid Use Disorder
...Opioid Intoxication
...Opioid Withdrawal
...Other Opioid-Induced Disorders
...Unspecified Opioid-Related Disorder

...Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
...Sedative, Hypnotic, or Anxiolytic Use Disorder
...Sedative, Hypnotic, or Anxiolytic Intoxication
...Sedative, Hypnotic, or Anxiolytic Withdrawal
...Other Sedative-, Hypnotic-, or Anxiolytic-Induced Disorders
...Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorder

...Stimulant-Related Disorders
...Stimulant Use Disorder
...Stimulant Intoxication
...Stimulant Withdrawal
...Other Stimulant-Induced Disorders
...Unspecified Stimulant-Related Disorder

...Tobacco-Related Disorders
...Tobacco Use Disorder
...Tobacco Withdrawal
...Other Tobacco-Induced Disorders

...Unspecified Tobacco-Related Disorder
...Other[/b] (or Unknown) Substance–Related Disorders
...Other (or Unknown) Substance Use Disorder
...Other (or Unknown) Substance Intoxication
...Other (or Unknown) Substance Withdrawal
...Other (or Unknown) Substance–Induced Disorders
...Unspecified Other (or Unknown) Substance–Related Disorder

Non-Substance-Related Disorders
Gambling Disorder

Neurocognitive Disorders 591

Delirium
Other Specified Delirium
Unspecified Delirium
Major and Mild Neurocognitive Disorders
Major Neurocognitive Disorder
Mild Neurocognitive Disorder
Major or Mild Neurocognitive Disorder Due to Alzheimer’s Disease
Major or Mild Frontotemporal Neurocognitive Disorder
Major or Mild Neurocognitive Disorder With Lewy Bodies
Major or Mild Vascular Neurocognitive Disorder
Major or Mild Neurocognitive Disorder Due to Traumatic Brain Injury
Substance/Medication-Induced Major or Mild Neurocognitive Disorder
Major or Mild Neurocognitive Disorder Due to HIV Infection
Major or Mild Neurocognitive Disorder Due to Prion Disease
Major or Mild Neurocognitive Disorder Due to Parkinson’s Disease
Major or Mild Neurocognitive Disorder Due to Huntington’s Disease
Major or Mild Neurocognitive Disorder Due to Another Medical Condition
Major or Mild Neurocognitive Disorder Due to Multiple Etiologies
Unspecified Neurocognitive Disorder

Personality Disorders 645

General Personality Disorder
Cluster A Personality Disorders
Paranoid Personality Disorder
Schizoid Personality Disorder
Schizotypal Personality Disorder
Cluster B Personality Disorders
Antisocial Personality Disorder
Borderline Personality Disorder
Histrionic Personality Disorder
Narcissistic Personality Disorder
Cluster C Personality Disorders
Avoidant Personality Disorder
Dependent Personality Disorder
Obsessive-Compulsive Personality Disorder
Other Personality Disorders
Personality Change Due to Another Medical Condition
Other Specified Personality Disorder
Unspecified Personality Disorder

Paraphilic Disorders 685

Voyeuristic Disorder
Exhibitionistic Disorder
Frotteuristic Disorder
Sexual Masochism Disorder
Sexual Sadism Disorder
Pedophilic Disorder
Fetishistic Disorder
Transvestic Disorder
Other Specified Paraphilic Disorder
Unspecified Paraphilic Disorder

Other Mental Disorders 707

Other Specified Mental Disorder Due to Another Medical Condition
Unspecified Mental Disorder Due to Another Medical Condition
Other Specified Mental Disorder
Unspecified Mental Disorder

Medication-Induced Movement Disorders and Other Adverse Effects of Medication 709

Other Conditions That May Be a Focus of Clinical Attention 715

Section III: Emerging Measures and Models

Assessment Measures 733

Cross-Cutting Symptom Measures
...DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure—Adult
...Parent/Guardian-Rated DSM-5 Level 1 Cross-Cutting Symptom Measure—Child Age 6 – 17
Clinician-Rated Dimensions of Psychosis Symptom Severity
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

Cultural Formulation 749

Cultural Formulation Interview (CFI)
Cultural Formulation Interview (CFI)—Informant Version

Alternative DSM-5 Model for Personality Disorders 761

Conditions for Further Study 783

Attenuated Psychosis Syndrome
Depressive Episodes With Short-Duration Hypomania
Persistent Complex Bereavement Disorder
Caffeine Use Disorder
Internet Gaming Disorder
Neurobehavioral Disorder Associated With Prenatal Alcohol Exposure
Suicidal Behavior Disorder
Nonsuicidal Self-Injury

A p p e n d i x

Highlights of Changes From DSM-IV to DSM-5 809

Glossary of Technical Terms 817

Glossary of Cultural Concepts of Distress 833

Alphabetical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM and ICD-10-CM) 839

Numerical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM) 863

Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 877

DSM-5 Advisors and Other Contributors 897


I n d e x 917

(Selventänyt ja täydentänyt Luukkonen)

[Psykopatologia]

Timetable: DSM "One" (1952) => DSM-5 (2013)

2.6.2013 18:08 Pertti Luukkonen Kulttuuri American Psychiatric Association (APA) David J. Kupfer diagnostiikka DSM-5 tautiluokitukset 4 kommenttia ilmoita asiaton viesti
Timetable: DSM "One" (1952) => DSM-5 (2013) Google: "Timetable DSM" http://perttiluukkonen.puheenvuoro.uusi ... dsm-5-2013

Benjamin Rush (1746 - 1813)



1) DSM ("One") (1952), jälkeen päin DSM-I. Diagnostic and Statistical Manual of Mental Disorders. Committee on Nomenclature and Statistics, 1951, Chairman George Neely Raines (1908 – 1959). Washington, D. C.: American Psychiatric Association (APA) Mental Hospital Service. – xii + 132 (144) p. – Google: “DSM-I pdf”

USN Captain George N. Raines

Huom. [106 diagnoosia] DSM yhtenäisti Yhdysvaltain sodanjälkeisen psykiatrisen diagnostiikan. Nykypäivästä katsoen suositeltu koodaus-proseduuri tuntuu yllättävän modernilta: se näyttää ennakoivan moniakseli-järjestelmää (vrt. DSM-III 1980). Häiriöt voitiin arvioida myös vaikeus-asteeltaan: mild, moderate, severe, käytäntö, jota ei ole koskaan noudatettu, vaikka se on ollut esillä vielä DSM-IV-TR:ssä (2000). (Diagnoosien määrissä on eri lähteissä eroa. Esittämäni luvut ovat kirjasta Shorter (2005): A Historical Dictionary of Psychiatry, pp. 90 – 91.)



2) DSM-II (1968). Diagnostic and Statistical Manual of Mental Disorders. Second Edition. Committee on Nomenclature and Statistics, 1967, Chairman Ernest Matsner Gruenberg (1915 – 1991), Spitzer Consultant. Washington, D. C.: APA. – xv + 119 (134) p. – Google: “DSM-II pdf”

Ernest M. Gruenberg

Huom. [182 diagnoosia] Otteeltaan DSM-II oli paljolti edeltäjänsä kaltainen; ne ovat ikään samasta puusta veistettyjä.



3) DSM-III (1980). Diagnostic and Statistical Manual of Mental Disorders. Third Edition. Task Force on Nomenclature and Statistics, Chairperson Robert Leopold ("Bob") Spitzer (1932–). Washington, D.C.: APA. – ix + 494 (503) p.

in the 1900's second to Kraepelin (1856 - 1926)

Huom. [265 diagnoosia] DSM-III merkitsi mullistusta psykiatrisessa diagnostiikassa, koska DSM-III:sa oli ensi kertaa käytössä (1) deskriptiivinen merkki-systeeminen diagnostiikka, joka ICD:ssä tuli käyttöön ICD-10:ssä (1992) vasta vuonna 1993 (DCR, Green book). Deksriptiivinen diagnostiikka - joka tuli jäädäkseen - paransi ratkaisevasti reliabiliteettia (ei niinkään validiteettia). Uutta oli myös (2) moni-akseli-systeemi. - 1990-luvun loppuun mennessä DSM: llä oli hegemonia neo-galtonilaisessa tutkimus-käytössä ympäri maailman ja vahva merkitys myös kliinisessä praktiikassa. ICD säilyi kuitenkin virallisena systeeminä. Yhdysvalloissa ICD-9-CM (clinical manual) on virallisena järjestelmänä 30.9.2014 saakka, ja 1.10.2014 lähtien ICD-10-CM.



4) DSM-III-R (1987) Diagnostic and Statistical Manual of Mental Disorders. Third Edition – Revised. Work Group to Revise DSM-III, Chair Spitzer, Kupfer member. – xxix + 567 (596) p.

Huom. [292 diagnoosia] Muutokset suhteessa DSM-III:teen olivat niin suuria, että kyseessä ei oikeastaan ollut revisio vaan kokonaan uusi laitos. Akseli V:n sisällöksi tuli GAF (Global Assessment of Functioning Scale), josta tuli puolivirallinen standardi Suomen psykiatrisiin epikriiseihin. Kuitenkaan moniakseli-järjestemä ei missään saavuttanut suurta suosiota (vrt. DSM-5).

Suomessa tilanne oli outo 1987 – 1995: Tautiluokitus 1987 (ICD-9) oli virallisena systeeminä, mutta häiriöiden nimet ja deskriptiiviset kriteerit olivat DSM-III-R:n (1987) mukaisia. Suomi oli amerikkalaistunut! Tämän myötä eurooppalaisen tradition mukainen psykopatologinen ote alkoi hiipua myös Suomessa. - Melko pian entiset depressiiviset neuroottiset kärsivätkin "vakavasta" masennuksesta, jolloin sama häiriö sai vaikeamman kaiun.


5) DSM-IV (1994). Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Task Force on DSM-IV, Chairperson Allen J. ("Al") Frances (1942–), Michael B. First Editor, Text and Criteria, Spitzer Special Adviser. – xxvii + 886 (913) p.

Allen J. Frances

Huom. [307 diagnoosia] Muutokset suhteessa DSM-III-R:ään olivat niin pieniä, että kyseessä oli kernaammin revisio kuin uusi laitos. Teksti ulottuu vuoden 1992 puoliväliin julkaisuun kirjallisuuteen. - First on luultavasti pitkälle vastuussa myös DSM-5:ssä (2013) olevista häiriöiden Criteria & Coding -"huonouksista".


6) DSM-IV-TR (2000). Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Work Groups for DSM-IV Text Revision, Co-Chairperson and Editor Michael B. First (1956–). – xxxvii + 943 (980) p.

Michael B. First

Huom. Diagnostiset kriteerit ovat samat kuin DSM-IV:sä. Tekstin uudelleen muokkaus ja lisäykset (1992–) alkoivat vuonna 1997.



7) DSM-5 (DSM-V; DSM-5.0) (18.5.2013). Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. DSM-5 Task Force (35), Chair David J. Kupfer (1941–), Dilip V. Jeste member (2007 - 2011; APA President 1012 - 2013): First, Editiorial and Coding Consultant. Arlington, VA: American Psychiatric Association (APA) & Washington, DC: American Psychiatric Publishing. – xliv + 947 (991) p. - ISBN 978-0-89042-551-1 (hardcover; 180 x 260 mm; 1695 g). - http://psychiatryonline.org/ - (Sain teoksen 31.5.2013.)

SECTION I: DSM-5 Basics (5 - 25)

SECTION II: Diagnostic Criteria and Codes (27 - 727)

SECTION III: Emerging Measures and Models (729 - 806)

SECTION IV: APPENDIX (807 - 916)

Huom. Kyseessä on suuri revisio, joka alkoi vuonna 1999. Moniakseli-järjestelmä on hylätty. Häiriöt on nyt jaettu – Section II: Diagnostic Criteria and Codes (pp. 27 – 727) – 22 pääluokkaan paljolti ajatellun biologisen samankaltaisuuden ym. pohjalta, esimerkiksi Neurodevelopmental Disorders, Schizophrenia Spectrum and Other Psychotic Disorders. (Mitään biologisia markkereita ei kuitenkaan pystytä esittämään, mikä oli toiveena DSM-IV:n (1994) jälkeen.) Section III: Emerging Measures and Models (pp. 729 – 806) sisältää tutkimustyöhön yms. liittyvää materiaalia, mm. Alternative DSM-5 Model for Personality Disorders (pp. 761 - 781 [21 p.]) - joka ei paljon kiinnosta kliinistä praktikanttia. – Manuaalissa on pyritty maksimoimaan ”harmonia” (Chair Steven E. Hyman) WHO:n ICD-11:n (2015) kanssa. – Google: ”DSM-5 Table of Contents pdf” (9 sivua)

DSM:n varsinaiset u u d e t laitokset ovat oikeastaan vuosilta 1952, [1968], 1980, [1987], [1994], [2000] ja 2013.

ISBN 978-0-89042-558-8 paperback; ISBN 978-0-89042-551-1 hardcover (no picture) has brownish deep purple cover with golden lines and letters representing devotion, security and royalty; a cover of the true "bible"!

DSM-6 released today (Kupfer) http://www.youtube.com/watch?v=RL_oYZT0c1o (3:21)

________ ___ _ David J. Kupfer

Pertti Luukkonen, Lic. Phil., psychotherapist; 2.->14.6.2013 2:25

viewtopic.php?f=10&t=4557

Psykopatologia - Granum http://granum.uta.fi/granum/index.php?kustantaja_id=241

Psykoptologia-foorumi index.php

[Psykopatologia]

http://www.docstoc.com/docs/116202309/B ... -Sartorius

[Psykopatologia]

http://www.eurekalert.org/pub_releases/ ... 051613.php

DSM-5 Table of Contents

Section I: DSM-5 Basics

Introduction
Use of the Manual
Cautionary Statement for Forensic Use of DSM-5

Section II: Categorical diagnoses

Neurodevelopmental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Bipolar and Related Disorders
Depressive Disorders
Anxiety Disorders
Obsessive-Compulsive and Related Disorders
Trauma- and Stressor-Related Disorders
Dissociative Disorders

Somatic Symptom and Related Disorders
Feeding and Eating Disorders
Elimination Disorders
Sleep-Wake Disorders
Sexual Dysfunctions
Gender Dysphoria
Disruptive, Impulse Control, and Conduct Disorders
Substance-Related and Addictive Disorders
Neurocognitive Disorders
Personality Disorders
Paraphilic Disorders
Other Mental Disorders
Medication-Induced Movement Disorders and Other Adverse Effects of Medication
Other Conditions That May Be a Focus of Clinical Attention

Section III: Emerging Measures and Models

Assessment Measures
Cultural Formulation
Alternative DSM-5 Model for Personality Disorders
Conditions for Further Study

Appendix

Highlights of Changes From DSM-IV to DSM-5
Glossary of Technical Terms
Glossary of Cultural Concepts of Distress
Alphabetical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM and ICD-10-CM)
Numerical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM)
Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
DSM-5 Advisors and Other Contributors

[Psykopatologia]

DSM-5: ORGANISAATIOITA & IHMISIÄ

(I) DSM-5 Task Force, Members

David J. Kupfer, M.D., Professor, Department of Psychiatry, University of Pittsburgh School of Medicine; Task Force Chair
Darrel A. Regier, M.D., M.P.H.; APA Director (Division of Research); Task Force Vice Chair
William E. Narrow, M.D., M.P.H.; APA Assocate Director (Div. of Research); Task Force Research Director

Dan Blazer, M.D., Ph.D., M.P.H., Duke University
Jack D. Burke Jr., M.D., M.P.H., Cambridge Health Alliance
William T. Carpenter Jr., M.D., University of Maryland
F. Xavier Castellanos, M.D., New York University
Wilson M. Compton, M.D., M.P.E., National Institute on Drug Abuse
Joel E. Dimsdale, M.D., University of California, San Diego
Javier I. Escobar, M.D., M.Sc., University of Medicine and Dentistry of New Jersey
Jan A. Fawcett, M.D., University of New Mexico
Bridget Grant, Ph.D., Ph.D., (2009–) National Institute on Alcohol Abuse and Alcoholism
Steven E. Hyman, M.D. (2007–2012), Harvard University
Dilip V. Jeste, M.D. (2007–2011), University of California, San Diego; APA President 2012–2013
Helena C. Kraemer, Ph.D., Stanford University
Daniel T. Mamah, M.D., M.P.E., Washington University in St. Louis
James P. McNulty, A.B., Sc.B., Mental Health Consumer Advocates of Rhode Island
Howard B. Moss, M.D. (2007–2009), University of Pennsylvania School of Medicine
Charles O'Brien, M.D., Ph.D., University of Pennsylvania
Roger Peele, M.D., D.L.F.A.P.A., Montgomery County Government; APA Secretary 2012–2013
Katharine A. Phillips, M.D., Brown University
Daniel S. Pine, M.D., National Institute of Mental Health (NIMH)
Charles F. Reynolds III, M.D., University of Pittsburgh
Maritza Rubio-Stipec, Sc.D., University of Puerto Rico
David Shaffer, M.D., F.R.C.P., F.R.C.Psych., Columbia University
Andrew E. Skodol II, M.D., University of Arizona
Susan Elizabeth Swedo, M.D., National Institute of Mental Health (NIHM)
Timothy B. Walsh, M.D., Columbia University
Philip Wang, M.D., Dr. P.H. (2007–2012), National Institute of Mental Health
William Womack, M.D., University of Washington
Kimberly A. Yonkers, M.D., Yale University
Kenneth J. Zucker, Ph.D., University of Toronto

Norman Sartorius, M.D., Ph.D., FRCPsych, International Consultant

Susan K. Schultz, M.D., University of Iowa; Text Editor
Emily A. Kuhl, Ph.D. (clinical psychology), University of Florida; APA Text Editor

Alla olevista *merkityt kuuluvat Task Forceen

(II) APA Division of Research Staff on DSM-5 (17)
*Darrel A. Regier, M.D., M.P.H.; APA Director, Division of Research

(III) APA Office of the Medical Director
James H. Scully Jr.,M.D., Medical Director and CEO

(IV) Editorial and Coding Consultants (2)
Michael B. First, MD, Columbia University Maria N. Ward, M.Ed., RHIT, CCS-P

(V) DSM-5 Work Groups (13)

1) ADHD and Disruptive Behavior Disorders (10 members),
*Chair David Shaffer, M.D., FRCP, Columbia University

2) Anxiety, Obsessive-Compulsive, Posttraumatic and Dissociative
*Chair Katharine A. Phillips, M.D., Brown University Disorders (15)

3) Childhood and Adolescent Disorders (8)
*Chair Daniel S. Pine, M.D., National Institute of Mental Health (NIMH)

4) Eating Disorders (12)
Chair B. Timothy Walsh, M.D., Columbia University

5) Mood Disorders (14)
*Chair Jan A Fawcett, M.D., University of New Mexico

6) Neurocognitive Disorders (10)
*Chair Emeritus (2007–2011) Dilip V. Jeste, M.D., University of California, San Diego
*Chair Dan G. Blazer, M.D., Ph.D., M.P.H., Duke University

7) Neurodevelopmental Disorders (14)
*Chair Susan Elizabeth Anderson Swedo, M.D., Chief, Pediatrics & Developmental Neuroscience Branch, NIMH
___________________________________________________________________________________________________________

8) Personality and Personality Disorders (11)
*Chair Andrew E. Skodol II, M.D., University of Arizona College of Medicine
Co-Chair John M. Oldham, M.D., M.S., Psychoanalytic Training 1969–1977 (APsaA), The Menninger Clinic (Houston)
Text Coordinator Robert F. Krueger, Ph.D., University of Minnesota
Renato D. Alarcon, M.D., M.P.H., Mayo Clinic College of Medicine
Carl C. Bell, M.D., University of Illinois at Chicago
Donna S. Bender, Ph.D., University of Arizona
Lee Anna Clark, Ph.D., University of Notre Dame
W. John Livesley, M.D., Ph.D. (2007–2012), Professor Emeritus, University of British Columbia
Leslie C. Morey, Ph.D., Texas A & M University
Larry J. Siever, M.D., Mount Sinai School of Medicine, Bronx VA Medical Center
Roel Verheul, Ph.D. (2008–2012), De Viersprong Institute, Nederland
__________________________________________________________________________________________________________

9) Psychotic Disorders (12)
*Chair William T. Carpenter Jr., M.D., University of Maryland

10) Sexual and Gender Identity Disorders (13)
*Chair Kenneth Zucker, Ph.D., C.Psych., University of Toronto

11) Sleep – Wake Disorders (7)
*Chair Charles F. Reynolds III, M.D., University of Pittsburgh

12) Somatic Symptoms Disorders (10)
*Chair Joel E. Dimsdale, M.D., University of California, San Diego

13) Substance-Related Disorders (16)
*Chair Charles P. O'Brien, M.D., Ph.D., University of Pennsylvania

(VI) DSM-5 Study Groups (6)

1) Diagnostic Spectra and DSM/ICD Harmonization
*Chair (2007–2012) Steven E. Hyman, M.D., Harvard University

2) Lifespan Developmental Approaches (9)
Chair Eric J. Lentze, M.D., Washington University School of Medicine
*Chair Emeritus Susan K. Schultz, M.D., University of Iowa
*Chair Emeritus Daniel S. Pine, M.D., National Institute of Mental Health (NIMH)

3) Gender and Cross-Cultural Issues (15)
Chair Kimberly A. Yonkers, M.D., Yale University

4) Psychiatric/General Medical Interfake (11)
Chair Lawson R. Wulsin., M.D., University of Cincinnati

5) Impairment and Disability (10)
Chair Jane S. Paulsen, Ph.D., University of Iowa

6) Diagnostic Assessment Instruments (7)
*Chair Jack D. Burke Jr., M.D., M.P.H., Cambridge Health Alliance

(VII) DSM-5 Research Group (7)
Chair William E. Narrow, M.D., M.P.H.; APA Assocate Director (Director of Research)

(VIII) Course Specifiers and Glossary (9)
Chair Wolfgang Gaebel, M.D., Heinrich-Heine-Universität Düsseldorf

DSM-5 (2013: vii – xii)

Google: “DSM-5 Task Force Members” http://www.dsm5.org/MEETUS/Pages/TaskForceMembers.aspx
Google: “DSM-5 Work Group Members http://www.dsm5.org/meetus/pages/work Chair groupmembers.aspx
Google: “DSM-5 Study Group Members” http://www.dsm5.org/MEETUS/Pages/StudyGroupMembers.aspx

[Psykopatologia]

Lyhenteet

APA = American Psychoanalytic Association, American Psychological Association, American Philosphical Association
APsaA = American Psychoanalytic Association
B.A. = Bachelor of Arts (Artium Baccalaureus)
CEO = Chief Executive Officer
Dr.P.H. = Doctor of Public Health
F.R.C.P. = Fellow of the Royal College of Physicians
F.R.C.Psych. = Fellow of the Royal College of Psychiatrists
LKT = lääketieteen ja kirurgian tohtori
LT = lääketieteen (ja kirurgian) tohtori
LTP = lifetime prevalence
M.D. = Doctor of Medicine (Medicinae Doctor)
MDE = major depressive episode
MDD = major depressive disorder
MD, PhD = suomalaisissa lääketieteellisissä julkaisuissa tarkoittaa väitellyttä (PhD) LT:tä
M.P.E. = Master of Psychiatric Epidemiology
M.P.H. = Master of Public Health
Ph.D. = Doctor of Philosophy (Philosphiae Doctor)
Sc.D. = Doctor of Science (Scientiae Doctor)
FT = filosofian tohtori

17.7.2013 14:45

[Helmenkalastaja]

Lyhenteet

B.A. = Bachelor of Arts (Artium Baccalaureus)
CEO
Dr.P.H. = Doctor of Public Health
F.R.C.P. = Fellow of the Royal College of Physicians
F.R.C.Psych. = Fellow of the Royal College of Psychiatrists
M.P.E. = Master of Psychiatric Epidemiology
M.P.H. = Master of Public Health
Sc.D. = Doctor of Science (Scientiae Doctor)

[Psykopatologia]

-tos!

[Kahvi]

CEO
(amerikanenglantia) chief executive officer: toimitusjohtaja

http://fi.wiktionary.org/wiki/CEO

Eiku olihan tuo lyhenne avattu PP:n listassa (Helmiksen listassa ei ollut, siksi intoilin)

[Psykopatologia]

Listani täydentyy jatkuvasti muokkauksen kautta (ei uusia viestejä;
alla oleva päivämäärä ilmaisee viimeisen (täydennyksen) muokkauksen
ajankohdan.

[Psykopatologia]

http://lcweb2.loc.gov/service/mss/eadxm ... 008011.pdf

Nolan D. C. Lewis Papers (3)

1936-1953 Director, New York Psychiatric Institute, New York, N.Y.
Professor, psychiatry and neurology, Columbia University, New York, N.Y.
1942-1958 Managing editor, Journal of Nervous and Mental Disease and Psychoanalytic Review
1945-1946 Consultant, Nuremberg War Crime Trials, Nuremberg, Germany
1953-1958 Director, research in neurology and psychiatry, New Jersey hospitals and agencies
1953-1966 Consultant, Veterans Administration hospitals
1979, Dec. 18 Died, Frederick, Md.

Scope and Content Note

The papers of Nolan Don Carpentier Lewis (1889 - 1979) span the years 1897-1978, with the bulk of the material dating from
1922 to 1958. Consisting of correspondence, patient files, drafts of writings, research files, reports, conference material, an
oral history interview, and printed matter, the material documents Lewis's contributions as a practicing psychoanalyst,
administrator, educator, and writer to the development of psychoanalysis in the United States and is organized into five
series: Correspondence, Patient File, Subject File, Writings File, and Printed Matter.
After graduating from the University of Maryland Medical School in 1914, Lewis worked primarily in general pathology and
neuropathology, serving successively as director of laboratories at Maryland General Hospital, Johns Hopkins University,
Phipps Psychiatric Clinic, and St. Elizabeths Hospital. While working in Baltimore between 1914 and 1918, Lewis studied
psychology at Johns Hopkins under Adolf Meyer and Charles MacFie Campbell and completed his psychoanalytic training
in Vienna where he attended lectures by Paul Schilder and others from 1927 to 1928. Lewis had two meetings with Sigmund
Freud while in Vienna. Between 1936 and 1953, he served as director of the New York Psychoanalytic Association. In 1953
he was named director of research in neurology and psychiatry for New Jersey hospitals and agencies. He taught at various
universities, including George Washington and Columbia, and served as editor of several journals.
The Correspondence series consists of letters from colleagues, professional organizations, editors of journals, and institutions
with which Lewis affiliated. Subjects discussed concern research projects, writing, lecturing, and other professional matters.
Among the prominent correspondents are A. A. Brill, Karl A. Menninger, Adolf Meyer, Clarence P. Oberndorf, and Sandor
Rado.

The Patient File dates primarily from the 1920s when Lewis served as pathologist and later as director of clinical psychiatry
at St. Elizabeths Hospital in Washington, D.C. This period was a formative decade in the development of psychoanalysis in
Washington, and in 1930, Lewis, along with Anna C. Dannemann Colomb, Lucile Dooley, Ernest Hadley, Edward Hiram
Reede, William Silverberg, and Harry Stack Sullivan, founded the Washington-Baltimore Psychoanalytic Society.
Although the Subject File series documents a variety of Lewis's professional activities, the bulk of the material concerns
dementia precox research and the Nuremberg War Crime Trials. In 1935, Lewis assumed the duties of coordinator for the
Committee on Research in Dementia Precox which oversaw research projects funded by the Supreme Council of the Scottish
Rite Masons of the Northern Jurisdiction. In 1936, Lewis published Research in Dementia Precox which explored advances
in research to that date. The files on dementia precox research include general correspondence, information on individual
projects, and annual reports sent to the Scottish Rite Masons. In 1946, Lewis attended the Nuremberg War Crime Trials as a
consultant to an ad hoc international psychiatric commission. The commission was established by the tribunal to determine
whether individual defendants were mentally competent to stand trial. Lewis was asked to examine Rudolf Hess, but like many
of the psychiatrists at Nuremberg, he took the opportunity to examine other defendants as well in an effort to understand the
psychological makeup of Nazi leaders. The most complete file of Nuremberg material concerns Hess and contains several
physicians' reports and notes from Lewis's examination. The series also includes Lewis's notes on Franz von Papen. A notebook
kept by Lewis during this period contains examination notes and general reflections on postwar Europe and the trials.

[Psykopatologia]

DSM:n “jättiläisiä” ovat ainakin:

Robert Leopold Spitzer (s. 1932) 1968 -> 1994
Janet W. B.Williamson (s. 1947) 1980 -> 1994
Roger Peele (s. 1930) 1980 -> 2013
David Reed Shaffer (s. 1946) 1980 -> 2013
Andrew Edward Skodoll II (s. 1945) 1980 -> 2013
Norman Sartorius (s. 1932) 1980 -> 2013
Allen J. Frances (s. 1942) 1980 -> 1994
Theodore Millon (s. 1928) 1980 -> 1994
David L. Kupfer (s. 1941) 1987 -> 2013
Darrel A. Regier (s. 1944) 1987 -> 2013
Michael B. First (s. 1965) 1987 -> 2013

[Psykopatologia]

(- -)
7) DSM-5 (DSM-V; DSM-5.0) (17.5.2013).

(- -)
2 Häiriöt ryhmiteltiin uudella tavalla 22 ydinryhmään tai spektrumiin esi-
merkiksi Neurodevelopmental disorders, Schizophrenia spectrum and other
psychotic disorders. – Rationaaleina ovat 1 samantyyppinen hermoverkko,
2 perhetausta, 3 geneettiset riskitekijät, 4 ympäristön spesifit riskitekijät,
5 biomarkkerit, 6 edeltävät temperamentti-tekijät, 7 emotionaalisten ja
kognitiivisten prosessien poikkeavuudet, 8 oireiden samankaltaisuus,
9 sairauden kulku, 10 korkea oheissairastavuus ja 11 samantyyppinen
hoitovaste. (Pp. 12 – 13.)

Kirjoittajat toteavat, että DSM-IV-TR:ssä (2000) diagnoosit olivat (mm. väärien positiivisten välttämiseksi)
"kategorisia" ja ”kapeita” ja että siksi tuloksena oli paljon päällekkäisyyttä, oheishäiriintyneisyyttä ja NOS-
diagnooseja. Kirjoittajien mukaan nykyinen struktuuri, jota he pitävät dimensionaalisena (ehkä siksi, että
häiriöt ovat nyt lähempänä toisiaan), välttää em. haittoja. (Kyseessä on kuitenkin horisontaalinen ”dimen-
sionaalisuus”; dimensionaalisuudella tarkoitetaan tavallisesti vertikaalista dimensionaalisuutta, esimerkiksi
vaikeusastetta häiriöille, joille monille on nyt entistä tarkempia määrityksiä.) Kirjoittajien mielestä nykyinen
rakennepohja antaa hyvän perustan sekä tutkimustyölle että kliiniselle käytännölle.
(- -)

[Psykopatologia]

(- -)
Kirjoittajien mukaan nykyinen struktuuri, jota he pitävät dimensionaalisena (ehkä siksi, että
häiriöt ovat nyt lähempänä toisiaan), välttää em. haittoja. (Kyseessä on kuitenkin horisontaalinen
”dimensionaalisuus”; dimensionaalisuudella tarkoitetaan tavallisesti vertikaalista dimensionaalisuutta,
esimerkiksi vaikeusastetta häiriöille, joille monille on nyt entistä tarkempia määrityksiä.)
(- -)

Onko DSM-5 -tiimi keksinyt uudentyyppisen "horisontaalisen dimensionaalisuuden"?

Tavallisimmin tuollaiseen käytetään faktorianalyysiä.

[Psykopatologia]

Conditions for Further Study (783)

1 Attenuated Psychosis Syndrome
2 Depressive Episodes with Short-Duration Hypomania
3 Persistent Complex Bereavement Disorder
4 Caffeine Use Disorder
5 Internet Gaming Disorder
5 Neurobehavioral Disorder Associated With Prenatal Alcohol Exposure
6 Suicidal Behavior Disorder
7 Nonsuicidal Self-Injury

1 & 3 ovat olleet kiisteltyjä.

5, 6 & 7 ovat kiintoisia.

Luultavasti julkaisen nuo suomeksi.

[Psykopatologia]

Personality Disorders (PDs) 645

Criteria: General Personality Disorder 646

Cluster A Personality Disorders 649
301.0 (F60.0) Paranoid Personality Disorder (PPD) 649
301.20 (F60.1) Schizoid Personality Disorder (SzPD) 652
301.22 (F21) Schizotypal Personality Disorder (STPD) 655

Cluster B Personality Disorders 659
301.7 (F60.2) Antisocial Personality Disorder (APD) 659
301.83 (F60.3) Borderline Personality Disorder (BPP) 663
301.50 (F60.4) Histrionic Personality Disorder (HPD) 667
301.81 (F0.81) Narcissistic Personality Disorder (NPD) 669

Cluster C Personality Disorders 672
301.82 (F60.6) Avoidant Personality Disorder (AvPD) 672
301.6 (F60.7) Dependent Personality Disorder (DPD) 675
301.4 (F60.5) Obsessive-Compulsive Personality Disorder (OCPD) 678

Other Personality Disorders 682
310.1 (F07.0) Personality Change Due to Another Medical Condition (PCSAMD) 682
301.89 (F60.89) Other Specified Personality Disorder (OSPD) 684
301.9 (F60.9) Unspecified Personality Disorder (UPD) 684

[Psykopatologia]

Liite 2 DSM-5 Table of Contents Short
xliv + 947 (991) p.

Section I: DSM-5 Basics (25 p.)
Introduction 5
Use of the Manual 19
Cautionary Statement for Forensic Use of DSM-5 25

Section II: Diagnostic Criteria and Codes (701 p.)
Categorical Diagnoses (27 – 727)

Neurodevelopmental Disorders 31
Schizophrenia Spectrum and Other Psychotic Disorders 87
Bi-polar and Related Disorders 123
Depressive Disorders 155
Anxiety Disorders 189
Obsessive-Compulsive and Related Disorders 235
Trauma- and Stressor-Related Disorders 265
Dissociative Disorders 291
Somatic Symptom and Related Disorders 309
Feeding and Eating Disorders 329
Elimination Disorders 355
Sleep – Wake Disorders 361
Sexual Dysfunctions 423
Gender Dysphoria 451
Disruptive, Impulse Control, and Conduct Disorders 461
Substance-Related and Addictive Disorders 481
Neurocognitive Disorders 591
Personality Disorders 645
Paraphilic Disorders 685
Other Mental Disorders 707
Medication-Induced Movement Disorders
...and Other Adverse Effects of Medication 709
Other Conditions That May Be a Focus of Clinical Attention 715

Section III: Emerging Measures and Models (78 p.)
Assessment Measures 733
Cultural Formulation 745
Alternative DSM-5 Model for Personality Disorders 761
Conditions for Further Study 783

A p p e n d i x (141 p.)
Highlights of Changes from DSM-IV to DSM-5 809
Glossary of Technical Terms 817
Glossary of Cultural Concepts of Distress 833
Alphabetical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM & ICD-10-CM) 839
Numerical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM) 863
Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 877
DSM-5 Advisors and Other Contributors 897
I n d e x 917 (–947)
______________________________________________________________________________________________________________________

DSM-5 Table of Contents xliv + 947 (991) p.

Contents v
DSM-5 Classification xiii
Preface xli

Section I: DSM-5 Basics (25 p.)

Introduction 5
Use of the Manual 19
Cautionary Statement for Forensic Use of DSM-5 25

Section II: Diagnostic Criteria and Codes (Categorical Diagnoses) (701 p.)

Neurodevelopmental Disorders 31
Intellectual Disabilities 33
Intellectual Disability (Intellectual Developmental Disorder)
Global Developmental Delay
Unspecified Intellectual Disability (Intellectual Developmental Disorder)
Communication Disorders 41
Language Disorder
Speech Sound Disorder (previously Phonological Disorder)
Childhood-Onset Fluency Disorder (Stuttering)
Social (Pragmatic) Communication Disorder
Unspecified Communication Disorder
Autism Spectrum Disorder 50
Autism Spectrum Disorder
Attention-Deficit/Hyperactivity Disorder 59
Attention-Deficit/Hyperactivity Disorder
Other Specified Attention-Deficit/Hyperactivity Disorder
Unspecified Attention-Deficit/Hyperactivity Disorder
Specific Learning Disorder 66
Specific Learning Disorder
Motor Disorders 74
Developmental Coordination Disorder
Stereotypic Movement Disorder
Tic Disorders
Tourette’s Disorder
Persistent (Chronic) Motor or Vocal Tic Disorder
Provisional Tic Disorder
Other Specified Tic Disorder
Unspecified Tic Disorder
Other Neurodevelopmental Disorders 86
Other Specified Neurodevelopmental Disorder
Unspecified Neurodevelopmental Disorder

Schizophrenia Spectrum and Other Psychotic Disorders 87
Schizotypal (Personality) Disorder (90) 655
Delusional Disorder
Brief Psychotic Disorder
Schizophreniform Disorder
Schizophrenia
Schizoaffective Disorder
Substance/Medication-Induced Psychotic Disorder
Psychotic Disorder Due to Another Medical Condition
Catatonia 119
Catatonia Associated with Another Mental Disorder (Catatonia Specifier)
Catatonic Disorder Due to Another Medical Condition
Unspecified Catatonia
Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
Unspecified Schizophrenia Spectrum and Other Psychotic Disorder

Bipolar and Related Disorders 123
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
Substance/Medication-Induced Bipolar and Related Disorder
Bipolar and Related Disorder Due to Another Medical Condition
Other Specified Bipolar and Related Disorder
Unspecified Bipolar and Related Disorder
Depressive Disorders 155
Disruptive Mood Dysregulation Disorder
Major Depressive Disorder, Single and Recurrent Episodes
Persistent Depressive Disorder (Dysthymia)
Premenstrual Dysphoric Disorder
Substance/Medication-Induced Depressive Disorder
Depressive Disorder Due to Another Medical Condition
Other Specified Depressive Disorder
Unspecified Depressive Disorder

Anxiety Disorders 189
Separation Anxiety Disorder
Selective Mutism
Specific Phobia
Social Anxiety Disorder (Social Phobia)
Panic Disorder
Panic Attack Specifier
Agoraphobia
Generalized Anxiety Disorder
Substance/Medication-Induced Anxiety Disorder
Anxiety Disorder Due to Another Medical Condition
Other Specified Anxiety Disorder
Unspecified Anxiety Disorder

Obsessive-Compulsive and Related Disorders 235
Obsessive-Compulsive Disorder
Body Dysmorphic Disorder
Hoarding Disorder
Trichotillomania (Hair-Pulling Disorder)
Excoriation (Skin-Picking) Disorder
Substance/Medication-Induced Obsessive-Compulsive and Related Disorder
Obsessive-Compulsive and Related Disorder Due to Another Medical Condition
Other Specified Obsessive-Compulsive and Related Disorder
Unspecified Obsessive-Compulsive and Related Disorder

Trauma- and Stressor-Related Disorders 265
Reactive Attachment Disorder
Disinhibited Social Engagement Disorder
Posttraumatic Stress Disorder
Acute Stress Disorder
Adjustment Disorders
Other Specified Trauma- and Stressor-Related Disorder
Unspecified Trauma- and Stressor-Related Disorder

Dissociative Disorders 291
Dissociative Identity Disorder
Dissociative Amnesia
Depersonalization/Derealization Disorder
Other Specified Dissociative Disorder
Unspecified Dissociative Disorder
Somatic Symptom and Related Disorders 309
Somatic Symptom Disorder
Illness Anxiety Disorder
Conversion Disorder (Functional Neurological Symptom Disorder)
Psychological Factors Affecting Other Medical Conditions
Factitious Disorder
Other Specified Somatic Symptom and Related Disorder
Unspecified Somatic Symptom and Related Disorder
Feeding and Eating Disorders 329
Pica
Rumination Disorder
Avoidant/Restrictive Food Intake Disorder
Anorexia Nervosa
Bulimia Nervosa
Binge-Eating Disorder
Other Specified Feeding or Eating Disorder
Unspecified Feeding or Eating Disorder
Elimination Disorders 355
Enuresis
Encopresis
Other Specified Elimination Disorder
Unspecified Elimination Disorder
Sleep – Wake Disorders 361
Insomnia Disorder
Hypersomnolence Disorder
Narcolepsy
Breathing-Related Sleep Disorders 378
Obstructive Sleep Apnea Hypopnea
Central Sleep Apnea
Sleep-Related Hypoventilation
Circadian Rhythm Sleep-Wake Disorders

Parasomnias 399
Non-Rapid Eye Movement Sleep Arousal Disorders
...Sleepwalking
...Sleep Terrors
Nightmare Disorder
Rapid Eye Movement Sleep Behavior Disorder
Restless Legs Syndrome
Substance/Medication-Induced Sleep Disorder
Other Specified Insomnia Disorder
Unspecified Insomnia Disorder
Other Specified Hypersomnolence Disorder
Unspecified Hypersomnolence Disorder
Other Specified Sleep-Wake Disorder
Unspecified Sleep-Wake Disorder
Sexual Dysfunctions 423
Delayed Ejaculation
Erectile Disorder
Female Orgasmic Disorder
Female Sexual Interest/Arousal Disorder
Genito-Pelvic Pain/Penetration Disorder
Male Hypoactive Sexual Desire Disorder
Premature (Early) Ejaculation
Substance/Medication-Induced Sexual Dysfunction
Other Specified Sexual Dysfunction
Unspecified Sexual Dysfunction

Gender Dysphoria 452
Gender Dysphoria
Other Specified Gender Dysphoria
Unspecified Gender Dysphoria
Disruptive, Impulse-Control, and Conduct Disorders 461
Oppositional Defiant Disorder
Intermittent Explosive Disorder
Conduct Disorder
Antisocial Personality Disorder 476 (659)
Pyromania
Kleptomania
Other Specified Disruptive, Impulse-Control, and Conduct Disorder
Unspecified Disruptive, Impulse-Control, and Conduct Disorder

Substance-Related and Addictive Disorders 481
Substance-Related Disorders 483
...Substance Use Disorders
...Substance-Induced Disorders
......Substance Intoxication and Withdrawal
......Substance/Medication-Induced Mental Disorders
...Alcohol-Related Disorders 490
...Alcohol Use Disorder
...Alcohol Intoxication
...Alcohol Withdrawal
...Other Alcohol-Induced Disorders
...Unspecified Alcohol-Related Disorder
...Caffeine-Related Disorders 503
...Caffeine Intoxication
...Caffeine Withdrawal
...Other Caffeine-Induced Disorders
...Unspecified Caffeine-Related Disorder
...Cannabis-Related Disorders 509
...Cannabis Use Disorder
...Cannabis Intoxication
...Cannabis Withdrawal
...Other Cannabis-Induced Disorders
...Unspecified Cannabis-Related Disorder
...Hallucinogen-Related Disorders 520
...Phencyclidine Use Disorder
...Other Hallucinogen Use Disorder
...Phencyclidine Intoxication
...Other Hallucinogen Intoxication
...Hallucinogen Persisting Perception Disorder
...Other Phencyclidine-Induced Disorders
...Other Hallucinogen-Induced Disorders
...Unspecified Phencyclidine-Related Disorder
...Unspecified Hallucinogen-Related Disorder
...Inhalant-Related Disorders 550
...Inhalant Use Disorder
...Inhalant Intoxication
...Other Inhalant-Induced Disorders
...Unspecified Inhalant-Related Disorder
...Opioid-Related Disorders 549
...Opioid Use Disorder
...Opioid Intoxication
...Opioid Withdrawal
...Other Opioid-Induced Disorders
...Unspecified Opioid-Related Disorder
...Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
...Sedative, Hypnotic, or Anxiolytic Use Disorder
...Sedative, Hypnotic, or Anxiolytic Intoxication
...Sedative, Hypnotic, or Anxiolytic Withdrawal
...Other Sedative-, Hypnotic-, or Anxiolytic-Induced Disorders
...Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorder
...Stimulant-Related Disorders 561
...Stimulant Use Disorder
...Stimulant Intoxication
...Stimulant Withdrawal
...Other Stimulant-Induced Disorders
...Unspecified Stimulant-Related Disorder
...Tobacco-Related Disorders 571
...Tobacco Use Disorder
...Tobacco Withdrawal
...Other Tobacco-Induced Disorders
...Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
...Other (or Unknown) Substance-Related Disorders 577
...Other (or Unknown) Substance Use Disorder
...Other (or Unknown) Substance Intoxication
...Other (or Unknown) Substance Withdrawal
...Other (or Unknown) Substance–Induced Disorders
...Unspecified Other (or Unknown) Substance–Related Disorder
Non-Substance-Related Disorders 585
Gambling Disorder

Personality Disorders (PDs) 645 – 684 (40 p.)
Criteria: General Personality Disorder 646
Cluster A Personality Disorders 649
301.0 (F60.0) Paranoid Personality Disorder (PPD) 649
301.20 (F60.1) Schizoid Personality Disorder (SzPD) 652
301.22 (F21) Schizotypal Personality Disorder (STPD) 655
Cluster B Personality Disorders 659
301.7 (F60.2) Antisocial Personality Disorder (APD) 659
301.83 (F60.3) Borderline Personality Disorder (BPP) 663
301.50 (F60.4) Histrionic Personality Disorder (HPD) 667
301.81 (F0.81) Narcissistic Personality Disorder (NPD) 669
Cluster C Personality Disorders 672
301.82 (F60.6) Avoidant Personality Disorder (AvPD) 672
301.6 (F60.7) Dependent Personality Disorder (DPD) 675
301.4 (F60.5) Obsessive-Compulsive Personality Disorder (OCPD) 678
Other Personality Disorders 682
310.1 (F07.0) Personality Change Due to Another Medical Condition (PCSAMD) 682
301.89 (F60.89) Other Specified Personality Disorder (OSPD) 684
301.9 (F60.9) Unspecified Personality Disorder (UPD) 684

Paraphilic Disorders 685
Voyeuristic Disorder
Exhibitionistic Disorder
Frotteuristic Disorder
Sexual Masochism Disorder
Sexual Sadism Disorder
Pedophilic Disorder
Fetishistic Disorder
Transvestic Disorder
Other Specified Paraphilic Disorder
Unspecified Paraphilic Disorder

[b]Other Mental Disorders 707[/b]
Other Specified Mental Disorder Due to Another Medical Condition
Unspecified Mental Disorder Due to Another Medical Condition
Other Specified Mental Disorder
Unspecified Mental Disorder

Medication-Induced Movement Disorders and Other Adverse Effects of Medication 709

Other Conditions That May Be a Focus of Clinical Attention (V,T, Z) 715


Section III: Emerging Measures and Models (78 p.)
Assessment Measures 733
Cross-Cutting Symptom Measures
...DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure – Adult
...Parent/Guardian-Rated DSM-5 Level 1 Cross-Cutting Symptom Measure – Child Age 6– 17
Clinician-Rated Dimensions of Psychosis Symptom Severity
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

Cultural Formulation 749
Cultural Formulation Interview (CFI)
Cultural Formulation Interview (CFI) – Informant Version

Alternative DSM-5 Model for Personality Disorders 761 – 781 (21 p.)

Conditions for Further Study 783

Attenuated Psychosis Syndrome
Depressive Episodes with Short-Duration Hypomania
Persistent Complex Bereavement Disorder
Caffeine Use Disorder
Internet Gaming Disorder
Neurobehavioral Disorder Associated With Prenatal Alcohol Exposure
Suicidal Behavior Disorder
Nonsuicidal Self-Injury


A p p e n d i x (141 p.)

Highlights of Changes From DSM-IV to DSM-5 809

Glossary of Technical Terms 817

Glossary of Cultural Concepts of Distress 833

Alphabetical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM and ICD-10-CM) 839

Numerical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM) 863

Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 877

DSM-5 Advisors and Other Contributors 897

I n d e x 917 (–947)

[Psykopatologia]

Alan Frances (1.6.2013): DSM-5 Badly Flunks the Writing Test (3 p.)
http://www.psychiatrictimes.com/dsm-5-b ... iting-test

Nyt kun olen käsitellyt kirjaa jo toista kuukautta, luulen että All'in arvion on aivan oikea.
(Hän itse kirjoittaa hyvin, kuten näemme Darwin-ketjussa.)

Vaikutelmaksi tulee puutteellinen oikoluku ja viimeistely. Kirjan piti vissiin valmistua jo
kevääksi 2012.

Omakohtainen havainto (p. xi):

Kun "Daniel S. Pine, M.D." on "Chair Emeritus",
niin tietysti myös "Susan K. Schultz" on "Chair Emeritus".

Kuka tahansa lukemaan tottunut torvi huomaisi virheen.